Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT ; volume:20 ; number:1 ; day:4 ; month:2 ; year:2022 ; pages:1-8 ; date:12.2022
Thrombosis journal ; 20, Heft 1 (4.2.2022), 1-8, 12.2022
- Creator
-
Myllylahti, Lasse
Pitkänen, Hanna
Magnani, Harry
Lassila, Riitta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-021-00362-y
- URN
-
urn:nbn:de:101:1-2022051320502467392178
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Myllylahti, Lasse
- Pitkänen, Hanna
- Magnani, Harry
- Lassila, Riitta
- SpringerLink (Online service)
Other Objects (12)
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications
Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study
Outcomes after decompressive surgery for severe cerebral venous sinus thrombosis associated or not associated with vaccine-induced Immune thrombosis with thrombocytopenia: a multicenter cohort study
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications
Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study
Outcomes after decompressive surgery for severe cerebral venous sinus thrombosis associated or not associated with vaccine-induced Immune thrombosis with thrombocytopenia: a multicenter cohort study
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications
Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study
Outcomes after decompressive surgery for severe cerebral venous sinus thrombosis associated or not associated with vaccine-induced Immune thrombosis with thrombocytopenia: a multicenter cohort study